Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: Phase IIIb LUCY final analysis - Balmana, J.; Fasching, Peter; Delaloge, S.; Park, Y. H.; Eisen, A.; Bourgeois, H.; Kemp, Z.; Jankowski, T.; Sohn, J.; Aksoy, S.; Timcheva, C. V.; Park-Simon, T-W.; et al. (ANNALS OF ONCOLOGY, 2022)
CRIS-Team WoS Importer:2022-06-03